iKang Accelerates Nationwide Network Expansion With 11 Medical Centers Joining iKang's Self-Owned Network

iKang Healthcare Group, Inc. ("iKang" or the "Company")

, China's largest private preventive healthcare services provider, today announced that it had acquired a 100% equity interest in Beijing Tianzhikangjian Investment Management Co., Ltd. ("Beijing Tianzhikangjian"), thereby indirectly acquiring an 82.85% equity interest in Beijing Tianjian Sunny Healthcare Technology Co., Ltd. ("Tianjian Sunny"). Tianjian Sunny, formerly known as Sinopharm Sunny, is a prominent medical examination center chain with 11 medical centers in 5 major cities in China. Tianjian Sunny was previously majority owned by China National Pharmaceutical Group Corporation ("Sinopharm"), a global Fortune 500 Company. Beijing Tianzhikangjian acquired all the equity interest in Tianjian Sunny owned by Sinopharm in April 2015, and has since become the largest shareholder of Tianjian Sunny. Tianjian Sunny's medical centers include six centers in Beijing, two centers in Hangzhou, one center in Changsha, one center in Wuhan, and one traditional Chinese medicine outpatient center in Guangzhou. Tianjian Sunny is a pioneer of medical examination services in China and enjoys a strong presence in Beijing. Mr. Lee Ligang Zhang, Chairman and Chief Executive Officer of iKang, commented on the acquisition. "We are very excited with the prospects of this acquisition across multiple fronts. First, the medical examination centers will be integrated into our extensive nationwide network, which will continue to enhance our leadership position in tier one cities like Beijing and further strengthen our presence in tier two cities like Hangzhou. Secondly, the acquisition will expand our reach to new cities such as Wuhan and Changsha, which translates to approximately 17 million people and comprise two of the most important markets in the middle of China. Combined with iKang and Tianjian Sunny, we now operate 17 medical centers in Beijing, and cement our place as the dominant player in the capital." He continued, "Last but not least, with the addition of the experienced and talented medical team, we will continue to consolidate our leadership position as the largest, best in class player in the preventive healthcare services market in China. On behalf of the rest of the management team, I extend our warm welcome and look forward to receiving them into the iKang family."